Actinium Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Actinium Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2011 to Q3 2024.
  • Actinium Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$11.6M, a 12.9% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$40.9M, a 18.4% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$48.8M, a 47.9% decline from 2022.
  • Actinium Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33M, a 33.3% decline from 2021.
  • Actinium Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$24.8M, a 11.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$40.9M -$11.6M +$1.71M +12.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$42.6M -$11.4M +$3.83M +25.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$46.5M -$8.67M +$2.37M +21.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$48.8M -$9.32M +$1.32M +12.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$50.1M -$13.3M -$3.8M -40.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$46.3M -$15.2M -$7.41M -95.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$38.9M -$11M -$5.91M -115% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$33M -$10.6M -$2.64M -32.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$30.4M -$9.47M -$3.05M -47.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$27.3M -$7.77M -$2.75M -54.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$24.6M -$5.13M +$191K +3.59% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$24.8M -$8.01M -$1.63M -25.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$23.1M -$6.42M -$883K -15.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$22.3M -$5.02M -$396K -8.56% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$21.9M -$5.32M +$350K +6.17% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$22.2M -$6.38M -$1.78M -38.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$20.4M -$5.54M +$1.06M +16% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$21.5M -$4.63M +$402K +8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$21.9M -$5.67M $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$21.9M -$4.6M +$1.72M +27.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$23.6M -$6.6M -$451K -7.33% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 -$23.2M -$5.03M -$164K -3.38% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$23M -$5.67M +$653K +10.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 -$23.7M -$6.32M -$1.16M -22.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-08
Q3 2018 -$22.5M -$6.15M +$175K +2.76% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$22.7M -$4.86M +$2.19M +31.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$24.9M -$6.32M +$1.74M +21.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$26.6M -$5.16M +$1.53M +22.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$28.1M -$6.32M +$276K +4.18% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$28.4M -$7.05M -$430K -6.49% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$28M -$8.06M -$3.66M -83.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$24.3M -$6.7M -$155K -2.37% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 -$24.2M -$6.6M -$2.65M -67.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$21.5M -$6.62M +$840K +11.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$22.4M -$4.4M -$1.33M -43.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$21M -$6.54M -$1.11M -20.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 -$19.9M -$3.95M +$2.13M +35.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 -$22M -$7.46M -$11M -312% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 -$11.1M -$3.07M +$13.6M +81.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$24.7M -$5.43M +$454K +7.72% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$25.1M -$6.08M -$4.66M -328% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 -$20.5M $3.52M +$6.3M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$26.8M -$16.7M -$16M -2324% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$10.8M -$5.88M -$3M -104% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 -$7.77M -$1.42M +$1.59M +52.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 -$9.36M -$2.78M -$1.22M -78.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$8.14M -$689K +$220K +24.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$8.36M -$2.88M -$2.87M Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 -$5.49M -$3.01M -$3.01M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$2.48M -$1.56M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$909K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$4.01K* Oct 1, 2011 Dec 31, 2011 10-Q 2012-04-23
Q3 2011 -$3.51K* Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.